| Autor: |
Vogel GE; Practice for Internal Medicine, Gastroenterology and Nephrology, Stievestrasse 5, 80638 Munich, Germany. Profvogel@t-online.de |
| Jazyk: |
angličtina |
| Zdroj: |
Medical microbiology and immunology [Med Microbiol Immunol] 2002 Dec; Vol. 191 (3-4), pp. 161-3. Date of Electronic Publication: 2002 Oct 25. |
| DOI: |
10.1007/s00430-002-0138-x |
| Abstrakt: |
The neuraminidase inhibitors signifies a breakthrough in the treatment of influenza. We compared the outcomes of influenza in 56 patients treated with zanamivir or oseltamivir to a group of 52 influenza patients from the time before these drugs were available. The duration of illness was reduced by 45%, the severity of symptoms by 40% and the administration of antibiotics by 32%. The data from this small group of patients of our ambulatory practice correspond to the results of large randomized placebo-controlled double-blind studies on zanamivir and oseltamivir. Our clinical observations and painful experiences have taught us to take every case of suspected influenza seriously. Since considerable influenza-related complications are common even in otherwise healthy individuals, patients should immediately consult their doctor when an illness with sudden onset of fever and cough or another respiratory symptom occur. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink